Leadership.
The team that took CarnaLife Holo through FDA and MDR, and that is now building the company around computer vision and Physical AI.
The people behind MedApp.
David Odrakiewicz
Chief Executive Officer
Andrzej Skalski
Chief Scientific Officer
Habeel Gazi
Chief Operating Officer, USA
Maciej Stanuch
Chief Product Officer
Supervisory Board.
All members of the supervisory board meet the independence criteria set out in the Polish Act of 11 May 2017 on statutory auditors, audit firms and public oversight.
Błażej Wasielewski
Chair of the Supervisory Board
Włodzimierz Kubiak
Supervisory Board Member
Michał Knapik
Supervisory Board Member
Malwina Grobelna
Supervisory Board Member
Ewelina Rytter
Supervisory Board Member
The company's three pillars.
- Holographic imaging
CarnaLife Holo
CT and MR studies turned into a three-dimensional hologram the surgeon looks at in the operating room and controls with a gesture. A device with FDA clearance and European MDR compliance.
Learn more - Procedure navigation
CarnaLife Holo MedNav
Mixed reality biopsy navigation: the patient's CT or MR superimposed onto the body, markerless needle and ultrasound probe tracking, and real-time fusion of 2D ultrasound with 3D imaging.
Learn more - Physical AI and robotics
Computer Vision
The company's key direction. The latest generation of vision models deployed in medical devices and robotic systems — with a deterministic safety layer above every decision.
Learn more